165 related articles for article (PubMed ID: 12827550)
21. Albumin mRNA in plasma predicts post-transplant recurrence of patients with hepatocellular carcinoma.
Cheung ST; Fan ST; Lee YT; Chow JP; Ng IO; Fong DY; Lo CM
Transplantation; 2008 Jan; 85(1):81-7. PubMed ID: 18192916
[TBL] [Abstract][Full Text] [Related]
22. Risk factors for fatal recurrence of hepatocellular carcinoma and their role in selecting candidates for liver transplantation.
Zou WL; Zang YJ; Chen XG; Shen ZY
Hepatobiliary Pancreat Dis Int; 2008 Apr; 7(2):145-51. PubMed ID: 18397848
[TBL] [Abstract][Full Text] [Related]
23. Determination of clonal origin of recurrent hepatocellular carcinoma for personalized therapy and outcomes evaluation: a new strategy for hepatic surgery.
Wang B; Xia CY; Lau WY; Lu XY; Dong H; Yu WL; Jin GZ; Cong WM; Wu MC
J Am Coll Surg; 2013 Dec; 217(6):1054-62. PubMed ID: 24246620
[TBL] [Abstract][Full Text] [Related]
24. [Semi-automated quantitative method for detecting the loss of heterozygosity at the long arm of chromosome 4 in hepatocellular carcinoma].
Bluteau O; Legoix P; Bayer J; Bioulac-Sage P; Fléjou JF; Capron F; Monges G; Brechot C; Thomas G; Laurent-Puig P; Zucman-Rossi J
Gastroenterol Clin Biol; 1999 Nov; 23(11):1225-32. PubMed ID: 10617833
[TBL] [Abstract][Full Text] [Related]
25. Molecular tools and hepatocellular carcinoma: Adding help or confusion in liver transplantation?
Vibert E; Samuel D
J Hepatol; 2008 Oct; 49(4):498-501. PubMed ID: 18678433
[No Abstract] [Full Text] [Related]
26. Liver transplantation for hepatocellular carcinoma: University Hospital Essen experience and metaanalysis of prognostic factors.
Sotiropoulos GC; Lang H; Nadalin S; Neuhäuser M; Molmenti EP; Baba HA; Paul A; Saner FH; Weber F; Hilgard P; Frilling A; Broelsch CE; Malagó M
J Am Coll Surg; 2007 Nov; 205(5):661-75. PubMed ID: 17964442
[TBL] [Abstract][Full Text] [Related]
27. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
[TBL] [Abstract][Full Text] [Related]
28. Fractional allelic loss in non-end-stage cirrhosis: correlations with hepatocellular carcinoma development during follow-up.
Roncalli M; Bianchi P; Grimaldi GC; Ricci D; Laghi L; Maggioni M; Opocher E; Borzio M; Coggi G
Hepatology; 2000 Apr; 31(4):846-50. PubMed ID: 10733538
[TBL] [Abstract][Full Text] [Related]
29. [Recurrence and metastasis of hepatocellular carcinoma after liver transplantation: single center experiences].
Zheng SS; Chen J; Wang WL; Zhang M; Shen Y; Wu J; Xu X; Yan S
Zhonghua Wai Ke Za Zhi; 2008 Nov; 46(21):1609-13. PubMed ID: 19094751
[TBL] [Abstract][Full Text] [Related]
30. Recurrence after liver resection for hepatocellular carcinoma: risk factors, treatment, and outcomes.
Shah SA; Cleary SP; Wei AC; Yang I; Taylor BR; Hemming AW; Langer B; Grant DR; Greig PD; Gallinger S
Surgery; 2007 Mar; 141(3):330-9. PubMed ID: 17349844
[TBL] [Abstract][Full Text] [Related]
31. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis.
Roayaie S; Schwartz JD; Sung MW; Emre SH; Miller CM; Gondolesi GE; Krieger NR; Schwartz ME
Liver Transpl; 2004 Apr; 10(4):534-40. PubMed ID: 15048797
[TBL] [Abstract][Full Text] [Related]
32. Frequent loss of heterozygosity on chromosome 22 in hepatocellular carcinoma.
Takahashi K; Kudo J; Ishibashi H; Hirata Y; Niho Y
Hepatology; 1993 May; 17(5):794-9. PubMed ID: 8387946
[TBL] [Abstract][Full Text] [Related]
33. Orthotopic liver transplantation for hepatocellular carcinoma: a thirteen-year single-center experience.
Castroagudín JF; Molina E; Bustamante M; Tomé S; Otero E; Martínez J; Segade FR; Conde R; Varo E
Transplant Proc; 2008 Nov; 40(9):2975-7. PubMed ID: 19010164
[TBL] [Abstract][Full Text] [Related]
34. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
[TBL] [Abstract][Full Text] [Related]
35. A gene expression profile for vascular invasion can predict the recurrence after resection of hepatocellular carcinoma: a microarray approach.
Ho MC; Lin JJ; Chen CN; Chen CC; Lee H; Yang CY; Ni YH; Chang KJ; Hsu HC; Hsieh FJ; Lee PH
Ann Surg Oncol; 2006 Nov; 13(11):1474-84. PubMed ID: 17009164
[TBL] [Abstract][Full Text] [Related]
36. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma.
Zavaglia C; De Carlis L; Alberti AB; Minola E; Belli LS; Slim AO; Airoldi A; Giacomoni A; Rondinara G; Tinelli C; Forti D; Pinzello G
Am J Gastroenterol; 2005 Dec; 100(12):2708-16. PubMed ID: 16393224
[TBL] [Abstract][Full Text] [Related]
37. Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum.
Chang YC; Ho CL; Chen HH; Chang TT; Lai WW; Dai YC; Lee WY; Chow NH
Br J Cancer; 2002 Dec; 87(12):1449-53. PubMed ID: 12454776
[TBL] [Abstract][Full Text] [Related]
38. Loss of heterozygosity on chromosomes 11 and 17 are markers of recurrence in TCC of the bladder.
Edwards J; Duncan P; Going JJ; Grigor KM; Watters AD; Bartlett JM
Br J Cancer; 2001 Dec; 85(12):1894-9. PubMed ID: 11747332
[TBL] [Abstract][Full Text] [Related]
39. Recurrence of hepatocellular carcinoma following liver transplantation: a review of preoperative and postoperative prognostic indicators.
Zimmerman MA; Ghobrial RM; Tong MJ; Hiatt JR; Cameron AM; Hong J; Busuttil RW
Arch Surg; 2008 Feb; 143(2):182-8; discussion 188. PubMed ID: 18283144
[TBL] [Abstract][Full Text] [Related]
40. Positive correlation between allelic loss at chromosome 14q24-31 and poor prognosis of patients with renal cell carcinoma.
Kaku H; Ito S; Ebara S; Ouchida M; Nasu Y; Tsushima T; Kumon H; Shimizu K
Urology; 2004 Jul; 64(1):176-81. PubMed ID: 15245966
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]